Artal Group S.A. Ovid Therapeutics Inc. Transaction History
Artal Group S.A.
- $1.58 Billion
- Q2 2024
A detailed history of Artal Group S.A. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Artal Group S.A. holds 2,500,000 shares of OVID stock, worth $3.25 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,500,000
Previous 2,500,000
-0.0%
Holding current value
$3.25 Million
Previous $7.63 Million
74.75%
% of portfolio
0.12%
Previous 0.41%
Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
77Shares Held
39.4MCall Options Held
10.3KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$6.91 Million0.12% of portfolio
-
Madison Avenue Partners, LP New York, NY4.08MShares$5.31 Million0.53% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$5.19 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$5.01 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$4.02 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $91.5M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...